Discover / Filter / Explore

Stock screener

Find the businesses that fit your questions.

Each company's latest annual period, from SEC filings. Monetary filters use the selected currency; amounts are never converted. Companies with no annual report in the last 18 months are left out unless you include them.

4,300 companies

Ticker	Company ▴	Revenue	Net income	Net margin	Return on equity	Revenue growth	Diluted EPS
AXS	Axis Capital Holdings Ltd Finance & Real Estate · Year ended 2025-12-31 · USD	$6.56B	$1.01B	15.4%	15.9%	10.2%	$12.35
AXON	Axon Enterprise, Inc. Manufacturing · Year ended 2025-12-31 · USD	$2.78B	$124.66M	4.5%	3.8%	33.5%	$1.51
AXTI	AXT Inc Manufacturing · Year ended 2025-12-31 · USD	$88.33M	-$21.26M	-24.1%	-7.2%	-11.1%	-$0.49
AYTU	Aytu Biopharma, Inc Manufacturing · Year ended 2026-06-30 · USD	$57.57M	-$14.25M	-24.8%	-40.4%	-13.3%	n/a
AZZ	AZZ Inc Manufacturing · Year ended 2026-02-28 · USD	$1.65B	$317.26M	19.2%	23.7%	4.6%	$10.50
AARD	Aardvark Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$57.59M	n/a	-54.0%	n/a	-$2.93
ABCL	AbCellera Biologics Inc. Manufacturing · Year ended 2025-12-31 · USD	$75.13M	-$146.41M	-194.9%	-15.1%	160.6%	-$0.49
ABX	Abacus Global Management, Inc. Finance & Real Estate · Year ended 2025-12-31 · USD	$235.24M	$36.53M	15.5%	8.7%	110.2%	$0.36
ABTS	Abits Group Inc Finance & Real Estate · Year ended 2025-12-31 · USD	$9.13M	-$2.87M	-31.4%	-36.9%	36.0%	-$1.21
ABLV	Able View Global Inc. Retail Trade · Year ended 2025-12-31 · USD	$105.20M	$820.0K	0.8%	10.6%	-17.0%	$0.02
ABSI	Absci Corp Services · Year ended 2025-12-31 · USD	$2.80M	-$115.18M	n/m	-60.8%	-38.2%	-$0.84
ASO	Academy Sports & Outdoors, Inc. Retail Trade · Year ended 2026-01-31 · USD	$6.05B	$376.77M	6.2%	17.4%	2.0%	$5.54
ACHC	Acadia Healthcare Company, Inc. Services · Year ended 2025-12-31 · USD	$3.31B	-$1.10B	-33.3%	-56.6%	5.0%	-$12.16
ACEL	Accel Entertainment, Inc. Services · Year ended 2025-12-31 · USD	$1.33B	$51.47M	3.9%	19.1%	8.1%	$0.60
ARX	Accelerant Holdings Finance & Real Estate · Year ended 2025-12-31 · USD	$912.90M	-$1.35B	-147.4%	-192.8%	51.5%	-$7.49
ACN	Accenture plc Services · Year ended 2026-08-31 · USD	$74.18B	$8.37B	11.3%	25.6%	6.5%	$13.56
ACCL	Acco Group Holdings Ltd Services · Year ended 2025-06-30 · USD	$4.85M	$1.02M	21.1%	46.7%	12.5%	$0.083
ACON	Aclarion, Inc. Services · Year ended 2025-12-31 · USD	$75.7K	-$7.23M	n/m	-56.4%	65.6%	-$13.61
ACRS	Aclaris Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$7.83M	-$64.92M	-829.6%	-63.0%	-58.2%	-$0.53
ACRV	Acrivon Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$77.91M	n/a	-69.2%	n/a	-$2.02
ATNM	Actinium Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$90.0K	-$33.89M	n/m	-432.6%	n/a	-$1.09
ABOS	Acumen Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$121.33M	n/a	-172.3%	n/a	-$2.00
ACXP	Acurx Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$7.97M	n/a	-151.2%	n/a	-$5.32
GOLF	Acushnet Holdings Corp. Manufacturing · Year ended 2025-12-31 · USD	$2.56B	$188.54M	7.4%	24.1%	4.1%	$3.11
ADAG	Adagene Inc. Manufacturing · Year ended 2025-12-31 · USD	$7.67M	-$17.61M	-229.6%	-49.8%	n/m	-$0.30

Rows per page: 2550 100